E-LIB Suche - Ergebnisse für: Wechsler, Michael

1

A new protocol for multispecies bacterial infections in zeb..:

Schmitz, Désirée A. ; Wechsler, Tobias ; Li, Hongwei Bran...
PLOS ONE. 19 (2024) 8 - p. e0304827 , 2024

Link: https://doi.org/10.1371/..

2

Long-term dupilumab efficacy in type 2 asthma regardless of..:

Wechsler, Michael E. ; Rogers, Linda ; Canonica, G. Walter...
ERJ Open Research. , 2024

Link: https://doi.org/10.1183/..

3

Biologic therapy in rare eosinophil-associated disorders: r..:

Khoury, Paneez ; Roufosse, Florence ; Kuang, Fei Li...
Journal of Leukocyte Biology. 116 (2024) 2 - p. 307-320 , 2024

Link: https://doi.org/10.1093/..

4

Long-Term Efficacy Of Dupilumab In Patients With Moderate-T..:

Wechsler, Michael ; Rogers, Linda ; Canonica, Giorgio...
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB96 , 2024

Link: https://doi.org/10.1016/..

5

Biomarkers and clinical outcomes after tezepelumab cessatio:

Brightling, Christopher E. ; Caminati, Marco ; Llanos, Jean-Pierre...
Annals of Allergy, Asthma & Immunology. , 2024

Link: https://doi.org/10.1016/..

6

International Variation in Severe Exacerbation Rates in Pat..:

Lee, Tae Yoon ; Price, David ; Yadav, Chandra Prakash...
CHEST. 166 (2024) 1 - p. 28-38 , 2024

Link: https://doi.org/10.1016/..

7

Ophthalmic vascular manifestations in eosinophil-associated..:

Chapuis, Elisa ; Bousquet, Elodie ; Viallard, Jean-François...
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

8

Oral and Inhaled Corticosteroid Dose Reductions With Tezepe..:

Wechsler, Michael E. ; Stolz, Daiana ; Lugogo, Njira L....
The Journal of Allergy and Clinical Immunology: In Practice. , 2024

Link: https://doi.org/10.1016/..

9

Long-term Efficacy of Dupilumab in Moderate-to-Severe Asthm..:

Wechsler, Michael E. ; Pavord, Ian D. ; Papi, Alberto...
CHEST Pulmonary. , 2024

Link: https://doi.org/10.1016/..

10

Efficacy of Tezepelumab in Patients with Severe, Uncontroll..:

Carr, Tara F. ; Moore, Wendy C. ; Kraft, Monica...
Advances in Therapy. 41 (2024) 7 - p. 2978-2990 , 2024

Link: https://doi.org/10.1007/..

11

TRLS-04. EARLY INSIGHTS FROM PNOC027: PERSONALIZED TREATMEN..:

Shatara, Margaret ; Paul, Megan R ; Long-Boyle, Janel R...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024

Link: https://doi.org/10.1093/..

12

TRLS-07. PNOC016: INTRATUMORAL PHARMACOKINETICS AND PHARMAC..:

Kline, Cassie ; Crawford, John R ; Reddy, Alyssa T...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024

Link: https://doi.org/10.1093/..

13

EPEN-26. DRUG SCREENING IN PATIENT-DERIVED MODELS OF POSTER..:

Larson, Jon D ; Finlay, Darren ; Murad, Rabi...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024

Link: https://doi.org/10.1093/..

14

What Every Clinician Should Know About Inflammation in COPD:

Wechsler, Michael E ; Wells, J Michael
ERJ Open Research. , 2024

Link: https://doi.org/10.1183/..

15

Long-Term Safety of Mepolizumab in EGPA: Results From the L..:

Khoury, Paneez ; Silver, Jared ; Wolff, Gerhard..
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB372 , 2024

Link: https://doi.org/10.1016/..